These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7658726

  • 1. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
    Terpstra W, Prins A, Visser T, Wognum B, Wagemaker G, Löwenberg B, Wielenga J.
    Leukemia; 1995 Sep; 9(9):1573-7. PubMed ID: 7658726
    [Abstract] [Full Text] [Related]

  • 2. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE.
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [Abstract] [Full Text] [Related]

  • 3. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE.
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human AML cells in NOD/SCID mice: engraftment potential and gene expression.
    Lumkul R, Gorin NC, Malehorn MT, Hoehn GT, Zheng R, Baldwin B, Small D, Gore S, Smith D, Meltzer PS, Civin CI.
    Leukemia; 2002 Sep; 16(9):1818-26. PubMed ID: 12200698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM, Yeager AM.
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
    Rombouts WJ, Martens AC, Ploemacher RE.
    Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
    [Abstract] [Full Text] [Related]

  • 17. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM, Wan TS, Leung JC, Chan LY, Huang H, Kwong YL, Liang R, Leung AY.
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of sublethal total body irradiation on acute graft-versus-host disease and graft-versus-leukemia effect in SCID mice.
    Sakai R, Maruta A, Yanoma S, Shimizu A, Harada M, Nakamura Y, Kodama F, Okubo T.
    Bone Marrow Transplant; 1997 Aug; 20(3):183-9. PubMed ID: 9257885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.